EP-I
|
他達(dá)拉非EP雜質(zhì)I
|
1795790-92-9
|
Tadalafil iMpurity D
|
TDF-M2-甲酰胺雜質(zhì)
|
951661-81-7
|
Fmoc-Ser(tBu)-Aib-OH
|
FMOC-SER(TBU)-AIB-OH
|
135875-33-1
|
FMOC-PRO-AIB-OH
|
FMOC-PRO-AIB-OH
|
109772-44-3
|
fmoc-lys(boc)-aib
|
|
|
Fmoc-β-Ala-Aib-OH
|
FMOC-Β-ALA-AIB-OH
|
107076-70-0
|
Fmoc-Val-Aib-OH
|
|
128422-18-4
|
Boc-Tyr(tBu)-Aib-Glu(OtBu)-GLY-OH
|
BOC-TYR(TBU)-AIB-GLU(OTBU)-GLY-OH
|
2682040-93-1
|
C20-OtBu-Glu-OtBu
|
|
|
Fmoc-lle-Aib-Leu-Asp(OtBu)-OH
|
|
|
Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH
|
替爾泊肽側(cè)鏈
|
2460751-66-8
|
EICOSANEDIOIC ACID
|
二十烷二酸
|
2424-92-2
|
AEEA-AEEA
|
17-氨基-10-氧代-3,6,12,15-四氧雜-9-氮雜十七烷酸
|
1143516-05-5
|
Fmoc-Ala-Gly-OH
|
FMOC-Β-ALA-GLY-OH
|
116747-54-7
|
Fmoc-Asp(OtBu)-Val-OH
|
FMOC-ASP(OTBU)-VAL-OH
|
131117-30-1
|
Fmoc-Tyr(tBu)-Leu-OH
|
FMOC-TYR(TBU)-LEU-OH
|
1122068-64-7
|
Fmoc-Gln(Trt)-Ala-Ala-OH
|
FMOC-GLN(TRT)-ALA-ALA-OH
|
|
Fmoc-Glu(OtBu)-Phe-OH
|
Fmoc-Glu(OtBu)-Phe-OH
|
1122076-55-4
|
Fmoc-Glu(OtBu)-Phe-Ile-Ala-OH
|
FMOC-GLU(OTBU)-PHE-ILE-ALA-OH
|
|
Z-PRO-PRO-OH
|
Z-PRO-PRO-OH
|
7360-23-8
|
(2S)-2-Amino-3-(tert-butoxy)propanamide hydrochloride
|
(2S)-2-氨基-3-叔丁氧基丙酰胺鹽酸鹽
|
323587-47-9
|
FMOC-GLY-PRO-OH
|
FMOC-GLY-PRO-OH
|
212651-48-4
|
H-Ser(tBu)-Ser(tBu)-Gly-OH
|
|
|
H-TYR(TBU)-OTBU HCL
|
TBU-酪氨酸叔丁酯鹽酸鹽
|
17083-23-7
|
Fmoc-D-Lys(Boc)-NH2
|
FMOC-D-LYS(BOC)-NH2
|
|
AC-PHE-OET
|
N-乙酰-L-苯丙氨酸乙酯
|
2361-96-8
|
FMOC-6-AHX-OSU
|
2,5-二氧代吡咯烷-1-基6-((((9H-芴-9-基)甲氧基)羰基)氨基)己酸酯
|
125697-63-4
|
Boc-His(Trt)-His(Trt)-OH
|
|
|
NA
|
0-叔丁基_D-別蘇氨酸叔丁酯
|
|
NA
|
O-叔丁基-D-蘇氨酸叔丁酯乙酸鹽
|
|
FMOC-lys-ome
|
(S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-6-氨基己酸甲酯
|
170943-16-5
|
Z-ABU(4)-OL
|
4-(Z-氨基)-1-丁醇
|
17996-13-3
|
Fmoc-His-Aib-OH TFA
|
FMOC保護(hù)二肽三氟乙酸鹽
|
1446013-08-6
|
Boc-His(Boc)-Aib-OH
|
|
|
Ste-Glu-AEEA-AEEA-OSU
|
十八烷二酸-谷氨酸-AEEA-AEEA-OSU
|
1169630-40-3
|
Pal-Glu(OSU)-OH
|
(S)-5-((2,5-二氧代吡咯烷-1-基)氧基)-5-氧代-2-棕櫚酰胺基戊酸
|
294855-91-7
|
Pal-Glu-Otbu-OH
|
N-十六酰基-L-谷氨酸 Α-叔丁酯
|
536721-25-2
|
Fmoc-Lys(Pal-Glu-OtBu)-OH
|
N2-[芴甲氧羰基]-N6-[N-(1-氧代十六烷基)-L-GAMMA-谷氨酰]-L-賴氨酸 1'-叔丁酯
|
1491158-62-3
|
Pal-Glu(OSu)-OtBu
|
NΕ-棕櫚?;?L-谷氨酸Γ-琥珀酰亞胺基-Α-叔丁酯
|
204521-63-1
|
FMOC-AIB-LEU-OH
|
FMOC-AIB-LEU-OH
|
107076-69-7
|
OCTADECANEDIOIC ACID
|
十八烷二酸
|
871-70-5
|
Octadecanedioic acid mono-tert-butyl ester
|
十八烷二酸單叔丁酯
|
843666-40-0
|
Fmoc-L-Lys[OctotBu)-Glu-(otBu)-AEEA-AEEA]-OSu
|
索馬魯肽雜質(zhì)17
|
1118767-15-9
|
tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu
|
索馬魯肽側(cè)鏈98
|
1118767-16-0
|
Fmoc-ser(tbu)-Gly
|
N-(((9H-芴-9-基)甲氧基)羰基)-O-(叔丁基)-L-絲氨酰甘氨酸
|
81672-17-5
|
Fmoc-(L)-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH
|
索馬魯肽中間體99
|
1662688-20-1
|
Fmoc-Gly-Arg(pbf)-OH
|
司美格魯肽片段
|
660846-80-0
|
Fmoc-His-Aib-OH
|
索瑪魯肽二肽側(cè)鏈
|
1446013-07-5
|
Fmoc-AEEA
|
2-[2-(Fmoc-氨基)乙氧基]乙氧基]乙酸
|
166108-71-0
|
fmoc-aeea-aeea
|
FMOC-8-氨基-3,6-二噁辛?;?8-氨基-3,6-二噁辛酸
|
560088-89-3
|
Fmoc-Lys(mtt)-OH
|
Fmoc-N'-甲基三苯甲基-L-賴氨酸
|
167393-62-6
|
fmoc-lys(alloc)
|
N-[(9H-芴-9-甲氧基)羰基]-N'-[(2-丙烯氧基)羰基]-L-賴氨酸
|
146982-27-6
|
(Fmoc-Thp-OH)
|
4-(FMOC-氨基)四氫吡喃-4-甲酸
|
285996-72-7
|
fmoc-his(mtt)
|
NΑ-FMOC-N(IM)-(4-甲基三苯甲基)-L-組氨酸
|
133367-34-7
|
Tadalafil impurity 38
|
中間體雜質(zhì)E
|
185750-07-6
|
Tadalafil Impurity 91
|
(1R,3R)-1-(苯并[d][1,3]二氧基-5-基)-2,3,4,9-四氫-1H-吡啶并[3,4-b]吲哚-3-羧酸乙酯鹽酸鹽
|
1158815-27-0
|
TDF-LB-M2
|
他達(dá)拉非雜質(zhì)30
|
629652-44-4
|
TDF-YXA
|
乙酰胺基他達(dá)拉非
|
1446144-71-3
|
Tadalafil EP Impurity
|
他達(dá)拉非雜質(zhì)P
|
479545-76-1
|
TDF-ZZS/TDF-2J-M1-COOH
|
他達(dá)那非二聚體雜質(zhì)
|
1598416-03-5
|
TDF-N-YBC
|
2-羥基丙基去甲他達(dá)拉非
|
1353020-85-5
|
(1R,3R)-2-acetyl-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro- 1H-pyrido[3,4-b]indole-3-carboxylate
|
TDF-DA-乙酰基-M1
|
1598416-05-7
|
2,3-(METHYLENEDIOXY)BENZALDEHYDE
|
1,3-苯并二氧-4-甲醛
|
7797-83-3
|
TDF-LA-M2
|
(1S,3S)-1-(1,3-苯并二惡唑-5-基)-2-(2-氯乙?;?2,3,4,9-四氫-1H-吡啶[3,4-b]吲哚- 3-羧酸甲酯
|
629652-42-2
|
DB-M2
|
(1S,3R)-1-苯并[1,3]二氧雜-5-基-2-(2-氯乙?;?2,3,4,9-四氫-1H-b-咔啉-3-羧酸甲基酯
|
629652-40-0
|
Tryptophan-002
|
S-5-吲哚甲基海因
|
40856-80-2
|
Tadalafil Impurity 39
|
TDF-DA-M2-COOH雜質(zhì)
|
2058231-08-4
|
TDF-DB-M2-JXA
|
他達(dá)拉非雜質(zhì)C
|
951661-84-0
|
D-Tryptophan, N-(trifluoroacetyl)- (9CI)
|
D-N-三氟乙酰-色氨酸
|
22220-03-7
|
API
|
艾曲波帕乙醇胺
|
496775-62-3
|
TDF-DB-M1-JXA
|
他達(dá)拉非雜質(zhì)A
|
951661-85-1
|
53692T
|
他達(dá)拉非雜質(zhì)92
|
1863191-32-5
|
Levosimendan
|
Levosimendan
|
36725-41-4
|
N-[4-(2-bromopropanoyl)phenyl]acetamide
|
1-(4-乙酰氨基苯基)-Α-溴代-1-丙酮
|
63514-63-6
|
D3-EZLA-S1
|
2-氟-4-[(1-甲氧基-2-甲基-1-氧代-2-丙基)氨基]苯甲酸甲酯
|
1802242-47-2
|
S2-Z01
|
艾曲波帕乙醇胺雜質(zhì)17
|
2500321-37-7
|
1437383-35-1
|
艾曲波帕苯甲醚雜質(zhì)
|
1437383-35-1
|
Levosimendan Impurity 14
|
右西孟旦/(S)-N-(4-(4-甲基-6-氧代-1,4,5,6-四氫噠嗪-3-基)苯基)羰基亞肼基丙二腈
|
144238-75-5
|
Levosimendan
|
左西孟旦
|
141505-33-1
|
Levosimendan Impurity 16
|
左西孟旦—右旋脫氨基雜質(zhì)
|
2290570-69-1
|
Levosimendan Impurity 10
|
左西孟旦左旋中間體羥基雜質(zhì)
|
134678-47-0
|
3-(2-Hydroxyphenyl)benzoic acid
|
3-(2-羥基苯基)苯甲酸
|
893736-72-6
|
Levosimendan-001
|
左西孟旦標(biāo)準(zhǔn)品001
|
244077-42-7
|
D3-EZLA-IM2
|
脫甲基酰胺雜質(zhì)
|
1242137-16-1
|
4-(4-acetamidophenyl)-3-methyl-4-oxobutanoic acid
|
3-(4-乙酰氨基苯甲?;?丁酸
|
36725-26-5
|
M2-ZA05
|
EBP氯代物雜質(zhì)
|
376592-56-2
|
diethyl 2-(1-(4-acetaMidophenyl)-1-oxopropan-2-yl)Malonate
|
左西孟旦中間體
|
81937-39-5
|
Levosimendan Impurity 8
|
左西孟旦-左旋反式腈乙酰胺雜質(zhì)(E型)/(R,E)左西孟旦-氰乙酰胺雜質(zhì)
|
274263-65-9
|
4-((2-carboxypropan-2-yl)amino)-2-fluorobenzoic acid| (API-ZZJ)
|
4-(2-甲基丙氨酸-2-氨基)-2-氟苯甲酸
|
1332524-02-3
|
asn(trt)-leu.otbu
|
叔丁基 N4-三苯甲基-L-天冬酰胺基-L-亮氨酸酯
|
1431625-52-3
|
TDF-M2-2YA
|
Diethylaminopretadalafil
|
1588526-67-3
|
NA
|
O-叔丁基L別蘇氨酸叔丁酯
|
|
4-(4-Aminophenyl)-3-methyl-4-oxobutanoic acid
|
4-(4-氨基苯基)-3-甲基-4-氧代丁酸
|
42075-29-6
|
N-[4-(AMinocarbonyl)-3-fluorophenyl]-2-Methylalanine
|
2 - ((4-氨基甲?;?3-氟苯基)氨基)-2-甲基丙酸
|
1242137-20-7
|
NA
|
左西孟旦-消旋乙酰噠嗪酮
|
|
Levosimendan Impurity 4
|
左西孟旦-消旋反式腈乙酰胺雜質(zhì)
|
131741-37-2
|
Enzalutamide
|
恩雜魯胺
|
915087-33-1
|
Levosimendan Impurity 2
|
左西孟旦消旋中間體羥基雜質(zhì)
|
103416-88-2
|
Boc-His(Trt)-Aib-OH
|
N-BOC-N'-三苯甲基-L-組氨酰-2-甲基丙氨酸
|
2061897-68-3
|
FMOC-ILE-AIB-OH
|
FMOC-ILE-AIB-OH
|
2171139-20-9
|